PARIS--(BUSINESS WIRE)--EOS imaging (NYSE Euronext, FR0011191766 – EOSI), the pioneer in orthopaedic 2D/3D imaging, today announced that the European Scanning Centre (ESC), based in London’s renowned Harley Street medical district, is the first independent center in the UK to install the EOS® System.
The EOS System provides full-body skeletal images of patients in a natural standing or seated position in both 2D and 3D, while delivering a radiation dose reported to be nine times lower than that of computed radiography X-ray1 and 20 times lower than basic CT scans2 to support the ALARA (As Low As Reasonably Achievable) principle of dose reduction.
Marie Meynadier, CEO of EOS imaging, said, “The EOS system is routinely used by medical centers around the world, with over 350,000 exams performed across 14 countries to date. We are very excited by this installation of EOS at the ESC as we continue to establish the system as the new standard of care for orthopaedic imaging in both the public and private sectors.”
Unique in orthopaedics, the EOS System is able to provide a broad range of clinical parameters following the scan that allow for more informed diagnosis, surgical planning and treatment of conditions including scoliosis, degenerative spine diseases and lower limb joint conditions. Recent research has demonstrated the advantages of holistic 3D imaging with EOS for assessing musculoskeletal alignment, particularly regarding the spine and lower limbs.3,4
Over the last 10 years, the European Scanning Centre in Harley Street has established itself as a leading independent diagnostic imaging centre by offering cutting edge technology, coupled with excellence in quality of image reporting. It is launching an advanced centre for musculoskeletal imaging, featuring the EOS System, that will provide a custom solution for orthopaedic conditions in one convenient location.
Dr. Paul Jenkins, Medical Director at the ESC, said, “This installation of EOS positions our center as a provider of state of the art imaging solutions for orthopaedics and musculoskeletal pathologies, and we are delighted to be the first independent centre in the UK to offer this technology.”
About EOS imaging:
The EOS imaging group designs, develops and markets EOS®, a revolutionary and patented medical imaging system, based on technology that enabled George Charpak to win the Nobel Prize for Physics. The Group has obtained authorization to market the system in 30 countries, including the United States (FDA), Canada, Australia and the European Union (EU). With an installed base of more than 60 sites and more than 350,000 imaging sessions, EOS® benefits from worldwide recognition and established credibility within the medical community. The Group currently employs 63 people, including an R&D team of 23 engineers, and recorded consolidated revenue of €9.42 million in 2012. The Group's head office is based in Paris, with 3 international subsidiaries in Cambridge (Massachusetts), Montreal and Germany. For further information, please go to: www.eos-imaging.com.
EOS imaging is listed on Compartment C of the NYSE Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI
Next update: half year 2013 revenues: July 17, 2013 after market close
1 S. Parent et al. Diagnostic imaging of spinal deformities: Reducing patients radiation dose with a new slot-scanning x-ray imager. Spine. April 2010, 35 (9): 989
2 D. Folinais et al. Lower Limb Torsional assessment: comparison EOS/CT Scan. JFR 2011.
3 Sagittal Balance of the Spine: Consequences for the Treatment of the Degenerative Spine. European Spine Journal. 2011
4 FM Buck et al. Femoral and Tibial Torsion Measurements With 3D Models Based on Low-Dose Biplanar Radiographs in Comparison With Standard CT Measurements. AJR 2012; 199:W607-W612; R Sutter et al. Three-dimensional hindfoot alignment measurements based on biplanar radiographs: comparison with standard radiographic measurements. Skeletal Radiol 2012